Pandemic Perspectives: Riding The Waves Of Asia’s Healthtech Innovation Explosion
A VC Investor’s view of healthtech developments during COVID-19 and beyond in the markets that account for 60% of the global population
Executive Summary
One year on, we’ve seen how the coronavirus prompted entrepreneurial instincts to surface in the medtech and healthtech sectors. Asia healthtech investor specialist HealthXCapital tells Medtech Insight about the changes that are likely to stick as in an industry that has seen the value of rapid responsiveness to acute need.